Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01387893 · ClinicalTrials.gov registry record · NA
A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia
A NA study of Benign Prostatic Hyperplasia, sponsored by Kaiser Permanente.
- Completed
- Registry status
- NA
- Development phase
- 48
- Enrollment target
- 1
- Study location
NCT01387893 is a NA study of Benign Prostatic Hyperplasia that has completed, run by Kaiser Permanente. The registered enrollment target is 48 participants, below the 550-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (91% lower). The trial reports 1 study location across 1 state.
The verdict
NCT01387893, a NA study of Benign Prostatic Hyperplasia, has completed, sponsored by Kaiser Permanente.
- COMPLETED
- Registry status
- NA
- Development phase
- 48 participants
- Enrollment target
- 1
- Study location
Study Summary
The objective of this study was to evaluate the effectiveness of the Digital Repetitive Infrapubic Pressure maneuver, a self-administered procedure used to provide symptomatic relief in initiating and maintaining urine flow impeded by benign prostatic hyperplasia.
Conditions Studied
Interventions
- BEHAVIORAL the Digital Repetitive Infrapubic Pressure maneuver
Study Locations (1)
California
- Kaiser Permanente - Santa Clara
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 48 participants |
| Start Date | 2008-05 |
| Est. Completion | 2009-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01387893
The ClinicalTrials.gov registry entry for NCT01387893 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 48 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 550-participant average among 29 other Benign Prostatic Hyperplasia trials with a reported enrollment target (91% lower). The listed sponsor is Kaiser Permanente, which has 294 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Benign Prostatic Hyperplasia appearing as the primary indexed condition, and to 1 intervention - of which the Digital Repetitive Infrapubic Pressure maneuver is the first listed.
NCT01387893 reports 1 study location spanning 1 distinct geographic area - top geographies include California.
Frequently Asked Questions
What is clinical trial NCT01387893 about?
NCT01387893 is a clinical study titled "A Self-Administered Maneuver to Relieve Symptoms Suggestive of Benign Prostatic Hyperplasia". The objective of this study was to evaluate the effectiveness of the Digital Repetitive Infrapubic Pressure maneuver, a self-administered procedure used to provide symptomatic relief in initiating and maintaining urine flow impeded by benign prostatic hyperplasia.
What is the current status of trial NCT01387893?
This trial is currently completed. It is a NA study. The enrollment target is 48 participants. The study started on 2008-05. Estimated completion is 2009-11.
What conditions does trial NCT01387893 study?
This clinical trial studies the following conditions: Benign Prostatic Hyperplasia.
What interventions are being tested in trial NCT01387893?
The interventions under investigation include: the Digital Repetitive Infrapubic Pressure maneuver (BEHAVIORAL).
Who is sponsoring clinical trial NCT01387893?
This trial is sponsored by Kaiser Permanente, which has 294 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01387893 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Benign Prostatic Hyperplasia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Ambulatory Long Length URodynamics Evaluation
RECRUITING · NA
-
Safety and Effectiveness of the Optilume® BPH Catheter System in a Post-Market Study
RECRUITING · NA
-
Sacral Neuromodulation for Male Overactive Bladder (MOAB)
RECRUITING · NA
-
A Clinical Study to Evaluate the Safety and Efficacy of the FloStent in Men With Benign Prostatic Hyperplasia Symptoms
RECRUITING · NA
-
5-Alpha Reductase 2 as a Marker of Resistance to 5ARI Therapy
RECRUITING · NA
-
PRescription Exercise for Older Men With Urinary Disease
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.